Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingWages, Salaries and Other
Ratios

Regenerative Medical Technology (RMTG) Long-Term Debt Issuances (2018 - 2021)

Historic Long-Term Debt Issuances for Regenerative Medical Technology (RMTG) over the last 4 years, with Q4 2021 value amounting to $1.0 million.

  • Regenerative Medical Technology's Long-Term Debt Issuances rose 85238.1% to $1.0 million in Q4 2021 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year change of. This contributed to the annual value of $12.4 million for FY2021, which is 166663.34% up from last year.
  • According to the latest figures from Q4 2021, Regenerative Medical Technology's Long-Term Debt Issuances is $1.0 million, which was up 85238.1% from $10.5 million recorded in Q2 2021.
  • In the past 5 years, Regenerative Medical Technology's Long-Term Debt Issuances ranged from a high of $10.5 million in Q2 2021 and a low of $28668.0 during Q1 2018
  • For the 4-year period, Regenerative Medical Technology's Long-Term Debt Issuances averaged around $915232.9, with its median value being $94559.0 (2019).
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first crashed by 1566.46% in 2020, then surged by 365939.85% in 2021.
  • Regenerative Medical Technology's Long-Term Debt Issuances (Quarter) stood at $74392.0 in 2018, then fell by 3.48% to $71801.0 in 2019, then soared by 46.24% to $105000.0 in 2020, then surged by 852.38% to $1.0 million in 2021.
  • Its last three reported values are $1.0 million in Q4 2021, $10.5 million for Q2 2021, and $900000.0 during Q1 2021.